PNEUMATOSIS CYSTOIDES INTESTINALIS

This adverse event was reported 35 times

These drugs are most commonly taken by patients reporting PNEUMATOSIS CYSTOIDES INTESTINALIS:

# Drug Count
0 METHOTREXATE 5
1 METHOTREXATE SODIUM 5
2 AMPHOTERICIN B 3
3 CYTARABINE 3
4 QUETIAPINE 3
5 VINCRISTINE SULFATE 3
6 ADRENALINUM 2
7 BEVACIZUMAB 2
8 EPINEPHRINE 2
9 FLUOROURACIL 2
See all common drugs associated with PNEUMATOSIS CYSTOIDES INTESTINALIS

PNEUMATOSIS CYSTOIDES INTESTINALIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE 1 0.0027
1 ESTERIFIED ESTROGENS, METHYLTESTOSTERONE 1 0.0027
2 MEXILETINE HYDROCHLORIDE 1 0.0024
3 CHLORPROMAZINE HYDROCHLORIDE 1 0.0010
4 INTERFERON GAMMA-1B 1 0.0007
5 ACETAMINOPHEN AND CODEINE PHOSPHATE 1 0.0005
6 COLESTIPOL HYDROCHLORIDE 1 0.0004
7 AMPHOTERICIN B 3 0.0002
8 GEFITINIB 2 0.0002
9 KETOROLAC TROMETHAMINE 1 0.0002
See all drugs enriched for association with PNEUMATOSIS CYSTOIDES INTESTINALIS

PNEUMATOSIS CYSTOIDES INTESTINALIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon gamma [EPC] 1 0.0007
1 Lipid-based Polyene Antifungal [EPC] 3 0.0002
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
3 Polyene Antifungal [EPC] 3 0.0001
4 Androgen [EPC] 1 0.0000
5 Sympathomimetic-like Agent [EPC] 1 0.0000
6 Catecholamine [EPC] 2 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
8 Muscle Relaxant [EPC] 1 0.0000
9 Insulin [EPC] 1 0.0000
See all drug classes enriched for association with PNEUMATOSIS CYSTOIDES INTESTINALIS